Global Clinical Packaging Organization

Small Pharma, Big Studies.

Xerimis is uniquely positioned to service the specific needs of small to mid-sized pharmaceutical companies. We know that the task of a modern day clinical packaging organization demands excellence in two key areas: an industry-leading knowledge of the landscape and its complexities along with a tireless dedication to client needs. At Xerimis, we understand the unique demands of your project, and we're here, alongside you, every step of the way.

Phase One

Phase I trials are the building blocks needed for all successful drug compounds. We work with our clients to develop the most user friendly designs to help ensure that the right drug is dispensed correctly at the right time.

Xerimis plus Xerimis plus Learn More About Phase One
Packaging Consultation
On Demand Labeling
Just-in-time Shipping
Fast Turnaround

Phase Two

Phase 2 trials bring more complexity and critical packaging decisions to the clinical development team. You can rely on Xerimis to help guide you through this process.

Xerimis plus Xerimis plus Learn More About Phase Two
Blinding Services
Protocol Specific Labeling
Pooled IDP/IMP Supply Chain Management
Procurement of Ancillary Supplies

Phase Three

Phase 3 trials typically draw on a large number of global sites to fill the enrollment needs of the study. Xerimis has extensive experience with global Phase 3 trials.

Xerimis plus Xerimis plus Learn More About Phase Three
Packaging Supply Management
Translation Services
IWRS/IVRS Consultation
Supply Chain Management
Depot Management

The path through a trial is complicated.
Let us make it easy for you.

Xerimis plus Xerimis plus Get Started

Agile Ability with Global Reach.

The benefits of an international player with the agility of something much more personal

Xerimis, US (HQ)
Xerimis, UK
Xerimis, Netherlands

Real-time Data.
From Anywhere.

We're constantly striving to provide our clients with a better, more comprehensive experience, and DashX is our latest evolution in fulfilling on that promise.

Xerimis plus Xerimis plus Register for a Free Test-drive

Insights & News

CMOs and CPOs: the Critical Difference

As the clinical supply industry evolves, so does its vernacular. Small molecules are making way for large ones, resulting in genetic therapies. We no longer work in ambient conditions; today, controlled room temperature best describes the handling process. Even the term sponsor company itself evolved from the fact that companies other than R&D pharmaceuticals are running trials.

blue-plus Continue Reading

Put to the Test: Flexibility in the Pandemic Age

These are unprecedented times in our industry. The immediate need for COVID-19 treatment and vaccine has created a clinical trials scenario that would’ve been unthinkable just six months ago. Vaccine development typically takes 10-15 years. Yet reports indicate that it took about eight weeks from first receiving the Coronavirus in labs to the first dosing of a test vaccine. Nearly every pharma company examined their commercial and clinical lines to find treatment potential that could help provide relief for the growing number of COVID patients. Now the world eagerly awaits news for effective treatments and ideally a vaccine.

blue-plus Continue Reading

Focused on Your FPI

The role of clinical supply is a very crucial link in the supply chain, yet one that is often glossed over by other groups along that chain. Many decisions are made upstream that have direct impacts on what can be done once a project is handed off to you and your team, without much consideration to the impact it has on the management of trials as it relates to dosing, formulation, delays, vendor selection, and perhaps most critically… milestones.

blue-plus Continue Reading